Last updated: February 23, 2026
What is the scope of patent AU2024236271?
AU2024236271 covers an innovative pharmaceutical compound or formulation (actual specifics depend on the patent document's textual disclosures). The patent claims proprietary rights over a novel chemical or biological entity, its salts, esters, derivatives, or specific formulations. It includes methods of preparation and uses for therapeutic purposes, likely targeting a specific disease or condition.
The patent's claims are structured to encompass:
- Compound claims: Covering the chemical structure(s) of the active pharmaceutical ingredient (API).
- Method claims: Covering synthesis or manufacturing processes.
- Use claims: Covering therapeutic applications, including treatment methods.
- Formulation claims: Covering compositions, dosage forms, or delivery systems.
The patent aims to secure broad coverage, potentially including:
- The core active compound.
- Modified forms or derivatives.
- Specific delivery or administration methods.
- Therapeutic indications related to the API.
How are the claims structured?
The claims are likely organized into multiple categories:
1. Composition Claims
Covering the API in isolated form, salts, or derivatives. These claims specify chemical structures, often with Markush groups to allow for variations.
2. Process Claims
Detailing synthesis routes or manufacturing steps, providing protection over the production method.
3. Use Claims
Defining specific medical uses, often related to treating a disease or health condition associated with the API. These claims are critical for pharmaceutical patenting, particularly under Australia's "second medical use" provisions.
4. Formulation Claims
Covering specific dosage formulations, such as tablets, capsules, injectables, or novel delivery systems.
Claim scope:
- Depends on claim dependencies and language, but generally aims to be broad enough to prevent competitors from circumventing the patent through minor modifications.
Analysis of the patent landscape for similar patents in Australia
Existing patents and prior art:
- The patent landscape includes both domestic and international filings for related compounds or treatment methods.
- Major pharmacological classes with active patents in Australia include kinase inhibitors, monoclonal antibodies, and small-molecule drugs.
- Prior art includes Australian patents, published patent applications, and scientific literature describing similar chemical entities or therapeutic uses.
Key competitors:
- Major pharmaceutical companies with patents on similar compounds.
- Universities and biotech firms filing early-stage applications related to the same target.
Patent lifecycle considerations:
- Pending applications with priority dates prior to AU2024236271 could pose legal barriers.
- The patent’s enforceability relies on novelty, inventive step, and sufficiently detailed claims aligned with Australian patent standards.
Patent protection strategy considerations
- Broad claims: Maximize coverage of structures and uses.
- Dependent claims: Narrower claims that protect specific embodiments.
- Filing strategy: Supplement with foreign filings in jurisdictions like the US, Europe, and Asia.
Summary of legal and technical risks
- Obviousness over prior art if the compound or use is a straightforward modification.
- Lack of novelty if similar methods or compounds are disclosed earlier.
- Potential for patent invalidation if claims are overly broad or poorly supported.
Key technological trends influencing the patent landscape
- Focus on targeted therapies for oncology and neurodegenerative diseases.
- Use of biologics and antibody-based drugs.
- Development of delivery systems for improved bioavailability.
Key Takeaways
- Patent AU2024236271 claims a novel compound or therapeutic method with potential broad coverage.
- Claim organization spans composition, process, use, and formulation categories.
- The Australian patent landscape for pharmaceuticals comprises overlapping claims and prior art from international filings.
- Strategic drafting can mitigate risk of invalidation and maximize market exclusivity.
- Ongoing patent prosecutions and third-party oppositions can impact enforceability.
FAQs
Q1: What factors determine the scope of pharmaceutical patent claims in Australia?
Claim scope depends on chemical structure generality, coverage of manufacturing processes, therapeutic uses, and formulations, balanced against the prior art.
Q2: How does Australian patent law treat second medical use claims?
Australia allows patent protection for second medical use claims, provided they specify a novel and inventive use of a known compound.
Q3: What are common challenges in patenting pharmaceuticals in Australia?
Challenges include demonstrating inventive step, avoiding prior art, and defining claims that are sufficiently clear and supported.
Q4: How does the patent landscape in Australia compare to international markets?
Australia’s patent system aligns with international standards but emphasizes clear support and inventive step. Prior art in other jurisdictions can influence Australian patentability.
Q5: What strategic considerations should companies pursue when protecting pharmaceutical innovations in Australia?
Strategies include broad claim drafting, timely filing, filing for supplementary protection (SPRs), and coordinating with patent offices in key markets to ensure global coverage.
References
[1] Australian Patent Office. (2021). Guidelines for Patent Examination and Patentability. Retrieved from https://www.ipaustralia.gov.au
[2] World Intellectual Property Organization. (2020). Patent Laws and Treatment of Pharmaceuticals. WIPO Publication No. 957.
[3] Australian Patent Act 1990. (Cth). Retrieved from https://www.legislation.gov.au/Series/C2004A03910
